Gastric carcinomas

被引:0
作者
Dominguez, S
Adenis, A
机构
[1] Ctr Oscar Lambret, Dept Cancerol Digest & Urol, F-59020 Lille, France
[2] Fac Libre Med, F-59046 Lille, France
关键词
gastric carcinoma; epidemiology; prognostic factors; surgery; radiation therapy; chemotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although its declining incidence in most Western countries, gastric cancer remains a leading cause of cancer death. In France, it ranks second after colorectal cancer in terms of frequency. Chronic gastritis is the most frequent pathological condition that predispose to gastric cancer. One of the most important aetiological factor of gastric carcinogenesis is obviously the infection by Helicobacter pylori. Positive diagnosis ofgastric cancer is made by ripper gastrointestinal endoscopy combined with biopsies. Surgical resection is currently the only potentially curative treatment, However, the 5-year-survival rate after apparently curative surgical resection remains only 15% in Western populations, The studies on adjuvant treatment after surgical resection, have failed to demonstrate any improvement in overall or disease-free survival, Although promising in the locally advance setting, the pre-operative cytotoxic approach with or without radiation therapy remains experimental. In advanced disease the so-called ECF regimen results in delayed symptoms-free survival increased survival (median: 9 months) and better quality of life.
引用
收藏
页码:1105 / 1118
页数:14
相关论文
共 166 条
  • [1] Adachi Y, 1998, BRIT J SURG, V85, P1281
  • [2] Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma
    Ajani, JA
    Mansfield, PF
    Lynch, PM
    Pisters, PW
    Feig, B
    Dumas, P
    Evans, DB
    Raijman, I
    Hargraves, K
    Curley, S
    Ota, DM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2403 - 2411
  • [3] PREOPERATIVE AND POSTOPERATIVE COMBINATION CHEMOTHERAPY FOR POTENTIALLY RESECTABLE GASTRIC-CARCINOMA
    AJANI, JA
    MAYER, RJ
    OTA, DM
    STEELE, GD
    EVANS, D
    ROH, M
    SUGARBAKER, DJ
    DUMAS, P
    GRAY, C
    VENA, DA
    STABLEIN, DM
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (22): : 1839 - 1844
  • [4] Ajani JA, 1998, CANCER J SCI AM, V4, P269
  • [5] Albert Clive, 1995, P197
  • [6] c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems
    Allgayer, H
    Babic, R
    Gruetzner, KU
    Tarabichi, A
    Schildberg, FW
    Heiss, MM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) : 2201 - 2209
  • [7] Allgayer H, 1997, CANCER, V80, P179, DOI 10.1002/(SICI)1097-0142(19970715)80:2<179::AID-CNCR2>3.0.CO
  • [8] 2-P
  • [9] *AM SOC GASTR END, 1988, GASTROINTEST ENDOSC, V34, P185
  • [10] ARSENE D, 1995, GASTROEN CLIN BIOL, V19, P797